Boardroom Alpha
Boardroom Alpha
RBKB · Current Report (Form 8-K) · Filed August 18, 2026

Rhinebeck Bancorp Inc — Current Report (Form 8-K)

Form
8-K
Filed
August 18, 2026
Period
Aug 18, 2026
Ticker
RBKB
Accession
0000943374-26-000390
Boardroom Alpha · Filing insights

Rhinebeck Bancorp appoints Suzanne Rhulen Loughlin to the board, joining Compensation and Governance/Nominating Committees.

About Rhinebeck Bancorp Inc
Market cap
$202M
1Y TSR
−3.2%
3Y TSR
+21.5%
Board grade
B
Sector
Financial Services
CEO
Matthew J Smith
Last annual meeting: May 19, 2026 · View full Rhinebeck Bancorp Inc profile →
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of earliest event reported): August 18, 2026
 
Rhinebeck Bancorp, Inc.
(Exact Name of Registrant as Specified in Charter)
 
 
           
Maryland
   
001-38779
 
83-2117268
(State or Other Jurisdiction)
of Incorporation)
   
(Commission File No.)
 
(I.R.S. Employer
Identification No.)
           
2 Jefferson Plaza, Poughkeepsie, New York
 
12601
(Address of Principal Executive Offices)
 
(Zip Code)
 
 
Registrant’s telephone number, including area code:    (845) 454-8555
 
 
Not Applicable
(Former name or former address, if changed since last report)
 
Securities registered pursuant to Section 12(b) of the Act:
 
 
 
 
 
 
Title of each class
 
Trading
Symbol(s)
 
Name of each exchange on which registered
Common Stock, par value $0.01 per share
 
RBKB
 
The NASDAQ Stock Market, LLC
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
   
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).     Emerging growth company 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 
 
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
On August 18, 2026, Rhinebeck Bancorp, Inc. (the “Company”) appointed Suzanne Rhulen Loughlin to the Board of Directors of the Company, effective immediately. Ms. Loughlin was appointed to each of the Compensation Committee and the Governance and Nominating Committee of the Board of Directors.
 
Ms. Loughlin is a co-founder and Executive Vice President of CrisisRisk Strategies, LLC. Before serving in this role, Ms. Loughlin served for two years as Chief Administrative Officer and General Counsel of a public company that provided support services for companies contracting with the government. In 2005, she founded Firestorm Solutions, LLC, a crisis management and planning consultancy which was sold in 2017. Before founding Firestorm, Ms. Loughlin was employed by Frontier Insurance Group, a publicly traded insurance holding company for 15 years, where her positions included in-house counsel, Managing Attorney of the in-house law firm, and Chief Administrative Officer of the public holding company. She also served as a director of the public insurance holding company. Ms. Loughlin serves as a board member of Hudson Valley Pattern for Progress and President of the Trevor Loughlin Foundation. Ms. Loughlin has served as a director of Rhinebeck Bank, the wholly-owned subsidiary of the Company, since 2011 and served as a director from 2019 until December 17, 2025.
 
There are no arrangements or understandings between Ms. Loughlin and any other persons pursuant to which she was selected as a director.  No information is required to be disclosed with respect to Ms. Loughlin pursuant to Item 404(a) of Regulation S-K.
 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
       
 
RHINEBECK BANCORP, INC.
   
   
   
Date:  August 18, 2026
By:
/s/ Matthew J. Smith
    Matthew J. Smith
   
President and Chief Executive Officer
 
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Rhinebeck Bancorp Inc (RBKB)

Reference

Frequently asked questions

When did Rhinebeck Bancorp Inc file this 8-K?
Rhinebeck Bancorp Inc (RBKB) filed this Current Report (Form 8-K) with the SEC on August 18, 2026. The accession number assigned by EDGAR is 0000943374-26-000390.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Rhinebeck Bancorp appoints Suzanne Rhulen Loughlin to the board, joining Compensation and Governance/Nominating Committees. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Rhinebeck Bancorp Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Rhinebeck Bancorp Inc has filed under CIK 1751783, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer